The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Correlative analysis to define patient profiles associated with manufacturing and clinical endpoints in relapsed/refractory multiple myeloma (RRMM) patients treated with idecabtagene vicleucel (ide-cel; bb2121), an anti-BCMA CAR T cell therapy.
 
Julie Rytlewski
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Adaptive Biotechnologies; Bristol-Myers Squibb
Patents, Royalties, Other Intellectual Property - Bristol-Myers Squibb
 
Jaymes Fuller
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
David R. Mertz
Employment - Bristol-Myers Squibb
Patents, Royalties, Other Intellectual Property - Georgia Institute of Technology
 
Ciara Freeman
Honoraria - AbbVie; Amgen; Bristol-Myers Squibb; Celgene; Incyte; Janssen; Sanofi; Seagen
Research Funding - Janssen; Teva
 
Salomon Manier
Consulting or Advisory Role - Abbvie (Inst); Adaptive Biotechnologies (Inst); Amgen (Inst); Celgene/Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Novartis (Inst)
Research Funding - Abbvie (Inst); Amgen (Inst); Celgene/Bristol-Myers Squibb (Inst); Janssen (Inst); Novartis (Inst); Takeda (Inst)
 
Nina Shah
Consulting or Advisory Role - Amgen; CareDX; CSL Behring; Genentech/Abbvie; GlaxoSmithKline; Indapta Therapeutics; Karyopharm Therapeutics; Kite, a Gilead company; Oncopeptides; Sanofi
Research Funding - Bluebird Bio; Celgene; Cellectis; Janssen; Nektar; poseida therapeutics; Precision Biosciences; Sutro biopharma; Teneobio
 
Timothy Brandon Campbell
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb